0001209191-20-001250.txt : 20200103 0001209191-20-001250.hdr.sgml : 20200103 20200103172449 ACCESSION NUMBER: 0001209191-20-001250 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191231 FILED AS OF DATE: 20200103 DATE AS OF CHANGE: 20200103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wiley Matthew T. CENTRAL INDEX KEY: 0001759703 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36621 FILM NUMBER: 20506878 MAIL ADDRESS: STREET 1: C/O FOAMIX PHARMACEUTICALS LTD. STREET 2: 2 HOLTZMAN ST, WEIZMANN SCIENCE PARK CITY: REHOVOT STATE: L3 ZIP: 7670402 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Foamix Pharmaceuticals Ltd. CENTRAL INDEX KEY: 0001606645 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 HOLZMAN ST. STREET 2: WEIZMANN SCIENCE PARK CITY: REHOVOT STATE: L3 ZIP: 76704 BUSINESS PHONE: 97289316233 MAIL ADDRESS: STREET 1: 2 HOLZMAN ST. STREET 2: WEIZMANN SCIENCE PARK CITY: REHOVOT STATE: L3 ZIP: 76704 FORMER COMPANY: FORMER CONFORMED NAME: Foamix Ltd. DATE OF NAME CHANGE: 20140428 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-31 0 0001606645 Foamix Pharmaceuticals Ltd. FOMX 0001759703 Wiley Matthew T. C/O FOAMIX PHARMACEUTICALS LTD. 2 HOLZMAN STREET REHOVOT L3 7670402 ISRAEL 0 1 0 0 Chief Commercial Officer Ordinary Shares 2019-12-31 4 F 0 2500 3.28 D 70782 D Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of the restricted share units and does not represent a sale by the Reporting Person. /s/ Mutya Harsch as attorney-in-fact 2020-01-03